ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

ACS Report Says Drop in Cancer Mortality Saved 898,000 Lives Over 17 Years

June 17, 2011

Guest Editorial “Gizmo Idolatry” and Marketing Da Vinci’s Radical Robot

September 26, 2014

ASCO Explores White, Minority Cancer Problem

July 13, 1990

House Appropriations Boosts NIH By $1 Billion In Draft Budget That Cuts Other HHS Programs

September 30, 2011

DCPC BSC Committee Okay Three Concepts

September 13, 1985

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012